Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-10-041469
Filing Date
2010-08-05
Accepted
2010-08-05 20:11:31
Documents
1
Period of Report
2010-08-05

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c04429_3x0.html 3  
1 MAIN DOCUMENT DESCRIPTION c04429_3x0.xml 3 10874
  Complete submission text file 0001209191-10-041469.txt   12958
Mailing Address 2929 ARCH STREET SUITE 1650 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 1650 PHILADELPHIA PA 19104 215-988-6800
BioAdvance Ventures L P (Reporting) CIK: 0001302567 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-34836 | Film No.: 10996021

Mailing Address 227 WASHINGTON STREET SUITE 200 CONSHOHOCKEN PA 19428
Business Address 227 WASHINGTON STREET SUITE 200 CONSHOHOCKEN PA 19428 484-567-0130
NUPATHE INC. (Issuer) CIK: 0001375200 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations